Metabolic engineering of plant cells for the production of pharmaceuticals

Información del proyecto

HEIKO MICHAEL: RISCH

Identificador del acuerdo de subvención: QLK4-CT-2002-51547

Fecha de inicio 1 Enero 2003

Fecha de finalización 31 Diciembre 2004

Financiado con arreglo a

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coste total € 130 768,00

Aportación de la UE € 130 768,00

Coordinado por

TECHNICAL RESEARCH CENTRE OF FINLAND
Finland

Objetivo

The project aims at developing new technologies based on functional genomic in which transgenic plant cell cultures are producing high contents of known or novel secondary metabolites to be used as pharmaceuticals.

Ámbito científico

• engineering and technology › industrial biotechnology › metabolic engineering
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs

Programa(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Tema(s)

• 1.1.1.-4. - Key action Environment and Health

Convocatoria de propuestas

Data not available

Régimen de financiación

RGI - Research grants (individual fellowships)

Coordinador

TECHNICAL RESEARCH CENTRE OF FINLAND

• Aportación de la UE: Sin datos
• Dirección: Tietotie 2 ; 02044 ESPOO ; Finlandia
• Coste total: Sin datos